Log In
Print
BCIQ
Print
Print this Print this
 

AVX-470

  Manage Alerts
Collapse Summary General Information
Company Avaxia Biologics Inc.
DescriptionOral inhibitor of tumor necrosis factor (TNF) alpha
Molecular Target Tumor necrosis factor (TNF) alpha
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat inflammatory bowel disease (IBD); Treat ulcerative colitis (UC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today